To direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era, and for other purposes.
Sponsors
Legislative Progress
Passed HouseReceived; read twice and referred to the Committee on Veterans' …
Passed House (inferred from eh version)
Mr. LaLota (for himself, Mr. Ryan, Mr. Fitzpatrick, Mr. Davis …
Summary
What This Bill Does
Requires VA to conduct epidemiological study on cholangiocarcinoma (bile duct cancer) prevalence in Vietnam veterans, a cancer linked to liver fluke parasites common in Southeast Asia.
Who Benefits and How
Vietnam veterans gain research attention to a cancer potentially linked to their service. Medical understanding of service-connected cancers improves. Potential future benefits eligibility may be informed.
Who Bears the Burden and How
VA must conduct study within 120 days, report within 1 year. CDC consultation required.
Key Provisions
- Study cholangiocarcinoma prevalence in Vietnam veterans
- Use VA Central Cancer Registry and National Program data
- Compare to general U.S. population rates
- Analyze by age, gender, race, ethnicity, geography
- Report to Congress with findings and recommendations
Evidence Chain:
This summary is derived from the structured analysis below. See "Detailed Analysis" for per-title beneficiaries/burden bearers with clause-level evidence links.
Primary Purpose
Studies liver fluke cancer in Vietnam veterans
Policy Domains
Legislative Strategy
"Research potential service-connected cancer in Vietnam veterans"
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "director"
- → CDC Director
- "secretary"
- → Secretary of Veterans Affairs
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology